⚖️

Pusat Topik

Peptida untuk menurunkan berat badan

Agonis reseptor GLP-1 seperti semaglutide dan tirzepatide telah mengubah manajemen berat badan. Jelajahi penelitian, bandingkan pilihan, dan pahami apa yang diharapkan.

Peptida Kunci

Artikel Terbaru

Review

Best Peptides for Visceral Fat Reduction: What the Research Shows

Visceral fat is the most metabolically dangerous fat in your body. These peptides have demonstrated …

Informational

GLP-1 Weight Loss Timeline: What to Expect Month by Month

Starting a GLP-1 receptor agonist for weight loss? Here's a month-by-month breakdown of what clinica…

Informational

How Peptides Control Appetite: The Science of Hunger Hormones

From GLP-1 to ghrelin, peptide hormones are the master regulators of hunger and satiety. This guide …

Guide

Peptide Weight Loss Programs: What They Actually Cost in 2026

From compounding pharmacies to branded medications and telehealth programs, the cost of peptide-base…

Review

Tirzepatide vs Retatrutide: Comparing Next-Generation Weight Loss Peptides

Tirzepatide is the current weight loss champion, but retatrutide — a triple-receptor agonist — is co…

Guide

Weight Loss Peptide Stack: Building an Evidence-Based Fat Loss Protocol

Combining peptides with complementary mechanisms can enhance fat loss, preserve muscle, and optimize…

Clinical

GLP-1 Receptor Agonists: A Comprehensive Comparison for Prescribers

Trying to figure out which GLP-1 medication is right for you? Here's a plain-English breakdown of th…

Clinical

GLP-1 and Exercise: How to Maximize Weight Loss with Physical Activity

Taking a GLP-1 medication? Here's why exercise isn't optional — and how to protect your muscles whil…

Penelitian

Post hoc analysis of randomized clinical trialPubMed

Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: SURPASS-CVOT

In a post hoc analysis of the landmark SURPASS-CVOT trial (n=13,165), tirzepatide demonstrated a 16%…

TirzepatideDulaglutide
Phase 3b randomized clinical trialPubMed

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: TOGETHER-PsA Trial

In the TOGETHER-PsA trial (n=271), combining tirzepatide with ixekizumab achieved ACR50 + ≥10% weigh…

Tirzepatide
Model-Informed Drug Development (MIDD) / Post-hoc AnalysisPubMed

Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach

This Novo Nordisk study used model-informed drug development to evaluate whether semaglutide 1.7 mg …

Semaglutide
Systematic Review and Meta-AnalysisPubMed

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Depression: A Systematic Review and Meta-Analysis

This comprehensive meta-analysis evaluated the association between GLP-1 receptor agonist use and de…

GLP-1 receptor agonistssemaglutideliraglutide
Retrospective cohort study (n=293)PubMed

Real-World Weight-Loss Outcomes in Weight-Reduced Patients Treated With Tirzepatide

This real-world study of 293 patients found that tirzepatide produced 10.3% total body weight loss i…

TirzepatideSemaglutide
Systematic review and meta-analysisPubMed

Glucagon-like Peptide-1 Receptor Agonists and Risk of Depression: A Systematic Review and Meta-Analysis

This comprehensive meta-analysis examined the relationship between GLP-1 receptor agonist use and de…

GLP-1 receptor agonistsSemaglutideLiraglutide

Panduan & Perbandingan

Solusi Terkait

← Jelajahi semua solusi